130 related articles for article (PubMed ID: 12698101)
1. Pomelo-induced increase in the blood level of tacrolimus in a renal transplant patient.
Egashira K; Fukuda E; Onga T; Yogi Y; Matsuya F; Koyabu N; Ohtani H; Sawada Y
Transplantation; 2003 Apr; 75(7):1057. PubMed ID: 12698101
[TBL] [Abstract][Full Text] [Related]
2. Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans.
Grenier J; Fradette C; Morelli G; Merritt GJ; Vranderick M; Ducharme MP
Clin Pharmacol Ther; 2006 Mar; 79(3):255-62. PubMed ID: 16513449
[TBL] [Abstract][Full Text] [Related]
3. Interaction between tacrolimus and nefazodone in a stable renal transplant recipient.
Olyaei AJ; deMattos AM; Norman DJ; Bennett WM
Pharmacotherapy; 1998; 18(6):1356-9. PubMed ID: 9855339
[TBL] [Abstract][Full Text] [Related]
4. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
Kuypers DR; Vanrenterghem Y
Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695
[TBL] [Abstract][Full Text] [Related]
5. Conversion of ciclosporin A to tacrolimus in kidney transplant recipients with chronic allograft nephropathy.
Tang SC; Chan KW; Tang CS; Lam MF; Leung CY; Tse KC; Li CS; Ho YW; Tong MK; Lai KN; Chan TM;
Nephrol Dial Transplant; 2006 Nov; 21(11):3243-51. PubMed ID: 16877482
[TBL] [Abstract][Full Text] [Related]
6. Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation.
Zhang X; Liu ZH; Zheng JM; Chen ZH; Tang Z; Chen JS; Li LS
Clin Transplant; 2005 Oct; 19(5):638-43. PubMed ID: 16146556
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus conversion in kidney transplant recipients: analysis of 107 patients.
Yağmurdur MC; Sevmis S; Emiroğlu R; Moray G; Bilgin N; Haberal M
Transplant Proc; 2004; 36(1):144-7. PubMed ID: 15013327
[TBL] [Abstract][Full Text] [Related]
8. Increase in renal vascular resistance after intake of cyclosporin A and tacrolimus and reversal by nitroglycerin spray: a study in patients with stable renal allograft function.
Weingart C; Leingärtner T; Bergler T; Krüger B; Böger C; Mack M; Banas B; Krämer BK
Int J Clin Pharmacol Ther; 2006 Sep; 44(9):422-7. PubMed ID: 16995330
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the temporal profile of calcineurin inhibition by cyclosporine and tacrolimus in renal transplant patients.
Koefoed-Nielsen PB; Karamperis N; Jørgensen KA
Transplant Proc; 2005 May; 37(4):1736-8. PubMed ID: 15919449
[TBL] [Abstract][Full Text] [Related]
11. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence.
Venkat VL; Nick TG; Wang Y; Bucuvalas JC
Pediatr Transplant; 2008 Feb; 12(1):67-72. PubMed ID: 18186891
[TBL] [Abstract][Full Text] [Related]
12. The effect of deoxyschisandrin on blood tacrolimus levels: a case report.
Jiang W; Wang X; Kong L
Immunopharmacol Immunotoxicol; 2010 Mar; 32(1):177-8. PubMed ID: 19656076
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute tacrolimus whole-blood elevation with phenobarbital in the pediatric liver transplant recipient.
Quirós-Tejeira RE; Chang IF; Bristow LJ; Karpen SJ; Goss JA
Pediatr Transplant; 2005 Dec; 9(6):792-6. PubMed ID: 16269053
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus dosing in Chinese renal transplant patients is related to MDR1 gene C3435T polymorphisms.
Li D; Gui R; Li J; Huang Z; Nie X
Transplant Proc; 2006 Nov; 38(9):2850-2. PubMed ID: 17112846
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
Fukudo M; Yano I; Masuda S; Fukatsu S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
Clin Pharmacol Ther; 2005 Aug; 78(2):168-81. PubMed ID: 16084851
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
Bartlomiejczyk I; Zochowska D; Sanko-Resmer J; Matuszewicz D; Paczek L
Transplant Proc; 2006; 38(1):94-6. PubMed ID: 16504673
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
Akbas SH; Yavuz A; Tuncer M; Yurdakonar E; Akcit F; Gurkan A; Demirbas A; Gultekin M; Ersoy F; Akaydin M
Transplant Proc; 2004; 36(1):86-8. PubMed ID: 15013308
[TBL] [Abstract][Full Text] [Related]
18. Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure.
Jevnikar A; Arlen D; Barrett B; Boucher A; Cardella C; Cockfield SM; Rush D; Paraskevas S; Shapiro J; Shoker A; Yilmaz S; Zaltzman JS; Kiberd B
Transplantation; 2008 Oct; 86(7):953-60. PubMed ID: 18852662
[TBL] [Abstract][Full Text] [Related]
19. Citrus grandis peel increases the bioavailability of cyclosporine and tacrolimus, two important immunosuppressants, in rats.
Lin SP; Chao PD; Tsai SY; Wang MJ; Hou YC
J Med Food; 2011 Nov; 14(11):1463-8. PubMed ID: 21883002
[TBL] [Abstract][Full Text] [Related]
20. Tripterygium wilfordii hook f increase the blood concentration of tacrolimus.
Wen J; Li L; Chen J; Ji S; Zheng C; Liu Z
Transplant Proc; 2008 Dec; 40(10):3679-82. PubMed ID: 19100464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
